Implications of the Emergence of a Novel H1 Influenza Virus
- 18 June 2009
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 360 (25), 2667-2668
- https://doi.org/10.1056/nejme0903995
Abstract
In this issue of the Journal, there are two reports of recent transmissions of swine influenza viruses in humans. One group of viruses, described by Shinde et al.,1 are triple reassortants of viruses from pigs, humans, and birds, called triple-reassortant swine influenza A (H1) viruses, which have circulated in pigs for more than a decade. The other group, described by the Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team,2 is a recent reassortant of the triple-reassortant swine influenza A (H1) viruses and a Eurasian swine influenza virus, resulting in the swine-origin influenza A (H1N1) virus (S-OIV), currently being transmitted among humans.Keywords
This publication has 7 references indexed in Scilit:
- Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009New England Journal of Medicine, 2009
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in HumansNew England Journal of Medicine, 2009
- Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré SyndromeThe Journal of Infectious Diseases, 2008
- Reflections on the 1976 Swine Flu Vaccination ProgramEmerging Infectious Diseases, 2006
- Influenza virus infections in infantsThe Pediatric Infectious Disease Journal, 1997
- Guillain-Barre syndrome in recipients of A/New Jersey influenza vaccineJAMA, 1980
- GUILLAIN-BARRE SYNDROME FOLLOWING VACCINATION IN THE NATIONAL INFLUENZA IMMUNIZATION PROGRAM, UNITED STATES, 1976–19771American Journal of Epidemiology, 1979